Impact of news drugs in the median overall survival of patients with metastatic castration resistant prostate cancer (mCRPC).
Natacha Chaumard-Billotey
Other Remuneration - PharmaMar; Roche
Sylvie Chabaud
No relevant relationships to disclose
Helen Jane Boyle
Honoraria - Janssen-Cilag; Novartis; Sanofi
Other Remuneration - Janssen-Cilag; Pfizer; Sanofi
Bertrand Favier
Honoraria - Roche
Other Remuneration - Pfizer; Roche
Yves Devaux
No relevant relationships to disclose
Jean-Pierre Droz
No relevant relationships to disclose
Aude Flechon
Honoraria - Janssen
Other Remuneration - Astellas Pharma; Sanofi